New Zealand markets closed

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.2600+0.0200 (+1.61%)
At close: 04:00PM EDT
1.2600 0.00 (0.00%)
After hours: 07:55PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CAD. All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
30/04/2020
Cash flows from operating activities
Net income
-25,202
-26,560
-16,709
-7,340
-4,947
Depreciation & amortisation
4,889
6,685
3,769
3,713
3,407
Deferred income taxes
-497
-926
-336
-83
-455
Stock-based compensation
2,392
1,943
3,083
2,748
739
Change in working capital
-2,252
-3,276
582
-1,018
-1,118
Accounts receivable
-1,092
-561
163
-439
-933
Inventory
-369
-185
-501
-316
-23
Accounts payable
171.996
-
-
-
171.996
Other working capital
-22,593
-21,328
-11,178
-2,027
-1,967
Other non-cash items
44
30
85
426
947
Net cash provided by operating activities
-20,999
-19,833
-9,921
-600
-1,391
Cash flows from investing activities
Investments in property, plant and equipment
-1,594
-1,495
-1,257
-1,427
-576
Acquisitions, net
-4,302
-592
-3,692
-1,029
-1,007
Sales/maturities of investments
140
80
0
-
-
Other investing activities
-49
40
-259
-
-
Net cash used for investing activities
-6,054
-1,967
-5,208
-2,456
-1,583
Cash flows from financing activities
Debt repayment
-1,073
-1,337
-962
-2,974
-915
Common stock issued
4,131
716
3,850
44,151
493
Other financing activities
-
-
-5
-
-
Net cash used provided by (used for) financing activities
3,053
-621
2,883
43,379
174
Net change in cash
-24,000
-22,421
-12,246
40,323
-2,800
Cash at beginning of period
38,439
30,047
41,838
2,691
5,539
Cash at end of period
14,439
8,366
30,047
41,838
2,691
Free cash flow
Operating cash flow
-20,999
-19,833
-9,921
-600
-1,391
Capital expenditure
-1,594
-1,495
-1,257
-1,427
-576
Free cash flow
-22,593
-21,328
-11,178
-2,027
-1,967